119 related articles for article (PubMed ID: 29782949)
1. Early detection of pancreatic cancers in liquid biopsies by ultrasensitive fluorescence nanobiosensors.
Kalubowilage M; Covarrubias-Zambrano O; Malalasekera AP; Wendel SO; Wang H; Yapa AS; Chlebanowski L; Toledo Y; Ortega R; Janik KE; Shrestha TB; Culbertson CT; Kasi A; Williamson S; Troyer DL; Bossmann SH
Nanomedicine; 2018 Aug; 14(6):1823-1832. PubMed ID: 29782949
[TBL] [Abstract][Full Text] [Related]
2. Early breast cancer screening using iron/iron oxide-based nanoplatforms with sub-femtomolar limits of detection.
Udukala DN; Wang H; Wendel SO; Malalasekera AP; Samarakoon TN; Yapa AS; Abayaweera G; Basel MT; Maynez P; Ortega R; Toledo Y; Bossmann L; Robinson C; Janik KE; Koper OB; Li P; Motamedi M; Higgins DA; Gadbury G; Zhu G; Troyer DL; Bossmann SH
Beilstein J Nanotechnol; 2016; 7():364-373. PubMed ID: 27335730
[TBL] [Abstract][Full Text] [Related]
3. Early Detection of Pancreatic Cancers Using Liquid Biopsies and Hierarchical Decision Structure.
Agarwal D; Covarrubias-Zambrano O; Bossmann SH; Natarajan B
IEEE J Transl Eng Health Med; 2022; 10():4300208. PubMed ID: 35937463
[TBL] [Abstract][Full Text] [Related]
4. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
Mayerle J; Kalthoff H; Reszka R; Kamlage B; Peter E; Schniewind B; González Maldonado S; Pilarsky C; Heidecke CD; Schatz P; Distler M; Scheiber JA; Mahajan UM; Weiss FU; Grützmann R; Lerch MM
Gut; 2018 Jan; 67(1):128-137. PubMed ID: 28108468
[TBL] [Abstract][Full Text] [Related]
5. Circulating Exosomes in Pancreatic Cancer: Will They Succeed on the Long, Littered Road to Early Detection Marker?
Babic A; Wolpin BM
Clin Chem; 2016 Feb; 62(2):307-9. PubMed ID: 26721295
[No Abstract] [Full Text] [Related]
6. Early Detection of Sporadic Pancreatic Ductal Adenocarcinoma: Problems, Promise, and Prospects.
Chari ST; Sharma A; Maitra A
Ann Intern Med; 2020 Apr; 172(8):558-559. PubMed ID: 32176886
[No Abstract] [Full Text] [Related]
7. Serum CA19-9, cathepsin D, and matrix metalloproteinase-7 as a diagnostic panel for pancreatic ductal adenocarcinoma.
Park HD; Kang ES; Kim JW; Lee KT; Lee KH; Park YS; Park JO; Lee J; Heo JS; Choi SH; Choi DW; Kim S; Lee JK; Lee SY
Proteomics; 2012 Dec; 12(23-24):3590-7. PubMed ID: 23065739
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for pancreatic cancer.
Dobiasch S; Szanyi S; Kjaev A; Werner J; Strauss A; Weis C; Grenacher L; Kapilov-Buchman K; Israel LL; Lellouche JP; Locatelli E; Franchini MC; Vandooren J; Opdenakker G; Felix K
J Nanobiotechnology; 2016 Dec; 14(1):81. PubMed ID: 27993133
[TBL] [Abstract][Full Text] [Related]
9. Screening for Pancreatic Cancer: Recommendation Statement.
Am Fam Physician; 2019 Dec; 100(12):Online. PubMed ID: 31845783
[No Abstract] [Full Text] [Related]
10. Urine test can detect early stage pancreatic cancer.
Bagcchi S
Lancet Oncol; 2015 Sep; 16(9):e431. PubMed ID: 26256762
[No Abstract] [Full Text] [Related]
11. Screening for Pancreatic Cancer.
Wada K; Takaori K; Traverso LW
Surg Clin North Am; 2015 Oct; 95(5):1041-52. PubMed ID: 26315522
[TBL] [Abstract][Full Text] [Related]
12. Conjugated polymer nanoparticles-based fluorescent biosensor for ultrasensitive detection of hydroquinone.
Liu Y; Wang YM; Zhu WY; Zhang CH; Tang H; Jiang JH
Anal Chim Acta; 2018 Jul; 1012():60-65. PubMed ID: 29475474
[TBL] [Abstract][Full Text] [Related]
13. Superparamagnetic iron oxide nanoparticles for MR imaging of pancreatic cancer: Potential for early diagnosis through targeted strategies.
Zhang C; Yan Y; Zou Q; Chen J; Li C
Asia Pac J Clin Oncol; 2016 Mar; 12(1):13-21. PubMed ID: 26663873
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic cancer and cancer screening programs: from nihilism to hope.
Pezzilli R; Corinaldesi R; Morselli-Labate AM
JOP; 2010 Nov; 11(6):654-5. PubMed ID: 21068511
[No Abstract] [Full Text] [Related]
15. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
Urayama S
World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935
[TBL] [Abstract][Full Text] [Related]
16. Identification of Small Proteins and Peptides in the Differentiation of Patients with Intraductal Mucinous Neoplasms of the Pancreas, Chronic Pancreatitis and Pancreatic Adenocarcinoma.
Fania C; Pezzilli R; Melzi d'Eril G; Gelfi C; Barassi A
Dig Dis Sci; 2018 Apr; 63(4):920-933. PubMed ID: 29417328
[TBL] [Abstract][Full Text] [Related]
17. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.
Hocker JR; Postier RG; Li M; Lerner MR; Lightfoot SA; Peyton MD; Deb SJ; Baker CM; Williams TL; Hanas RJ; Stowell DE; Lander TJ; Brackett DJ; Hanas JS
Cancer Lett; 2015 Apr; 359(2):314-24. PubMed ID: 25637792
[TBL] [Abstract][Full Text] [Related]
18. Early detection of sporadic pancreatic cancer: summative review.
Chari ST; Kelly K; Hollingsworth MA; Thayer SP; Ahlquist DA; Andersen DK; Batra SK; Brentnall TA; Canto M; Cleeter DF; Firpo MA; Gambhir SS; Go VL; Hines OJ; Kenner BJ; Klimstra DS; Lerch MM; Levy MJ; Maitra A; Mulvihill SJ; Petersen GM; Rhim AD; Simeone DM; Srivastava S; Tanaka M; Vinik AI; Wong D
Pancreas; 2015 Jul; 44(5):693-712. PubMed ID: 25931254
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic cancer: steps in the right direction.
Bates SE
Clin Cancer Res; 2012 Aug; 18(16):4248. PubMed ID: 22896690
[No Abstract] [Full Text] [Related]
20. Early detection of sporadic pancreatic cancer: strategic map for innovation--a white paper.
Kenner BJ; Chari ST; Cleeter DF; Go VL
Pancreas; 2015 Jul; 44(5):686-92. PubMed ID: 25938853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
